MeSH D004761 - pseudomembranous enterocolitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Abbott Biotherapeutics | Metronidazole | Metronidazole |  | 1983-11-18 |  |  |
| Able Laboratories | Metronidazole | Metronidazole |  | 2003-06-25 |  |  |
| Alembic Pharmaceuticals | Metronidazole | Metronidazole |  | 2009-06-23 |  |  |
| Alkem Laboratories | Vancomycin | Vancomycin |  | 2022-11-14 |  |  |
| Allergan | Metronidazole | Metronidazole |  | 1984-12-20 |  |  |
| Vancomycin | Vancomycin |  | 2012-04-09 |  |  | |
| Amneal Pharmaceuticals | Metronidazole | Metronidazole |  | 2023-05-24 |  |  |
| Vancomycin | Vancomycin |  | 2023-06-23 |  |  | |
| ANI Pharmaceuticals | Vancomycin | Vancocin |  | 1982-01-01 |  |  |
| APP Pharmaceuticals | Metronidazole | Metronidazole |  | 1984-12-03 |  |  |
| Appco Pharma | Metronidazole | Metronidazole |  | 2015-09-23 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%1/1
Phase 3
80%8/10
Approved: 7Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use